Range Low Price High Price Comment
30 days $1.76 $2.85 Tuesday, 30th Apr 2024 ATAI stock ended at $1.98. This is 0.508% more than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 7.89% from a day low at $1.90 to a day high of $2.05.
90 days $1.58 $2.85
52 weeks $1.03 $2.85

Historical ATA Inc. prices

Date Open High Low Close Volume
Feb 02, 2016 $5.42 $5.42 $5.42 $5.42 10 300
Feb 01, 2016 $5.34 $5.34 $5.34 $5.34 3 200
Jan 29, 2016 $5.43 $5.43 $5.43 $5.43 7 700
Jan 28, 2016 $5.20 $5.20 $5.20 $5.20 13 100
Jan 27, 2016 $5.63 $5.63 $5.63 $5.63 9 700
Jan 26, 2016 $5.30 $5.30 $5.30 $5.30 4 000
Jan 25, 2016 $5.41 $5.41 $5.41 $5.41 17 300
Jan 22, 2016 $5.47 $5.47 $5.47 $5.47 28 700
Jan 21, 2016 $5.19 $5.19 $5.19 $5.19 25 300
Jan 20, 2016 $5.17 $5.17 $5.17 $5.17 17 400
Jan 19, 2016 $5.53 $5.53 $5.53 $5.53 48 700
Jan 15, 2016 $5.55 $5.55 $5.55 $5.55 71 700
Jan 14, 2016 $5.65 $5.65 $5.65 $5.65 13 200
Jan 13, 2016 $5.76 $5.76 $5.76 $5.76 68 200
Jan 12, 2016 $5.35 $5.35 $5.35 $5.35 37 100
Jan 11, 2016 $5.05 $5.05 $5.05 $5.05 76 700
Jan 08, 2016 $5.90 $5.90 $5.90 $5.90 67 900
Jan 07, 2016 $6.35 $6.35 $6.35 $6.35 169 500
Jan 06, 2016 $7.19 $7.19 $7.19 $7.19 140 400
Jan 05, 2016 $6.53 $6.53 $6.53 $6.53 36 800
Click to get the best stock tips daily for free!

About ATA Inc.

ATA. Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modul... ATAI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT